Shorter radiation course for older adults with head and neck cancer
Part of Cancer clinical trials.
This trial tests a shorter course of radiation therapy (hypofractionated radiotherapy) specifically for older adults with head and neck cancer that has not spread. The aim is to make treatment more convenient and manageable while still being effective, potentially with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You have a type of head and neck cancer called squamous cell carcinoma (confirmed by biopsy).
- Your cancer has not spread to distant parts of your body (like the lungs or liver).
- Your cancer is early stage or locally advanced, and you are scheduled to receive radiation therapy (either as primary treatment or after surgery).
- You are generally in good health (able to care for yourself and do daily activities).
- You have not had radiation to the head or neck before, and your organs (like blood, kidneys, liver) are working well enough for radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a shorter course of radiation therapy (called hypofractionated radiotherapy) for people with head and neck cancer who have already had surgery to remove the tumor. It is for patients with certain 'intermediate-risk' features, aiming to improve outcomes while possibly reducing treatment time.
This trial tests whether giving a slightly different schedule of radiation (more frequent, smaller doses) can improve treatment for people with large head and neck cancers. It is for patients who are getting radiation as their main treatment, sometimes with chemotherapy as well.
This trial compares two shortened radiation therapy schedules for patients with advanced head and neck cancer that cannot be cured. The goal is to see which schedule provides better symptom relief and quality of life with fewer side effects.
This Phase 2 trial tests a specific, shorter type of focused radiation to help relieve symptoms from head and neck squamous cell carcinoma. It compares two radiation timing/planning approaches to see which better improves comfort and quality of life.
This trial looks at whether giving less (de-escalated) radiation after surgery is as effective and safer for people with locally advanced head and neck squamous cell carcinoma who had a strong response to treatment before surgery. If you had no remaining cancer or only very small amounts of cancer left in the surgical specimen, this approach may help reduce side effects while keeping control of the disease.
This study looks at using a special scan (F-MISO-PET) to see areas of low oxygen in head and neck cancer. The radiation dose is then customized to give higher doses to those low-oxygen areas, which may improve the chance of controlling the tumor.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.